Home Contents Search Glossary

Home Q&A 100 Introduction Part 1 Part 2 Part 3 Part 4 Part 5 Part 6 Part 7 Part 8 Part 9 Part 10 Part 11 Appendix

 

at www.Amazon.com

Copyright © 2003 by Jones and Bartlett Publishers, Inc.

All rights reserved. No part of the material protected by this copyright notice may be reproduced or utilized in any form, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission from the copyright owner.

 

 

100 Questions & Answers About Brain Tumors uses a novel approach to transmit information to patients and their families who seek understanding about myriad topics—from day-to-day living with a brain tumor, to coping with treatment side effects, to talking to friends, to changing priorities, and everything else in between. A patient’s comments and stories are interspersed with the doctor’s explanations.

 

Patients, caregivers, families and friends are guaranteed to learn from the answers and commentaries found here. Also, the healthcare team treating brain tumor patients will learn about those unasked questions that patients were afraid to ask, or too embarrassed to ask, or forgot to ask during their hospital stay or office visit.

During my fifteen years in the brain tumor community, I've witnessed an evolution in our society's acceptance of individuals diagnosed with a brain tumor. In the late 1980s, there was a reluctance to talk freely about it. A brain tumor was more than a disease—it was a stigma. A brain tumor can affect emotions, intellect, personality—the very essence of a person—and people are frightened if they witness such changes, especially if they don’t understand the cause. Location and histology of the tumor are determinant factors in such changes; their onset may be gradual or sudden. However, because few people were talking about brain tumors, the general public knew little about them.
 

Compared to other cancers, brain tumors have a relatively low incidence, making it an “orphan disease” by government standards, which classifies any disease with an annual incidence of less than 200,000 as an orphan disease. Our numbers today estimate 18,600 diagnoses of brain tumors annually, which includes over 120 different types of brain tumors.

I personally credit Mr. Lee Atwater for beginning to change society's attitude about brain tumors when he went public about his disease. In the early 1990s, Mr. Atwater was Chairman of the Republican National Committee under President George H.W. Bush. He was the first prominent person to announce that he was battling a brain tumor. I remember seeing him on the cover of Life magazine; I knew that his candor would make a difference for future patients. According to published accounts at the time, Mr. Atwater had a reputation for being a “bad boy” in politics, but I firmly believe he made amends for any misdeeds he may have done by coming forward and empowering people to speak openly about brain tumors.

My, how far we've come. The past decade has brought newer diagnostic and microsurgical tools and techniques, more effective treatment therapies for some brain tumors, a proliferation of brain tumor-focused organizations and support groups, and many patient education publications, including a significant library of booklets and pamphlets written by the American Brain Tumor Association. And most notably, having a brain tumor is no longer a stigma. Rather, this past decade has produced a generation of information-seekers who have a driving need to have their questions answered.


The intriguing aspect of this book is its approach: provocative questions and honest answers given by a clinician and a patient. This resource for brain tumor patients and their families brings home the fact that no one needs to feel they are battling this disease alone.

 

Ms. Dubay has encountered the disease, the healthcare professionals, the medical system, and the unasked questions of family and friends. She answers questions and provides commentaries on issues that only a patient would know how to address. The brain tumor community-at-large will benefit from her firsthand knowledge.

 

Dr. Stark-Vance responds to questions with clarity, candor, and sound medical expertise. She does not sugarcoat her answers, nor does she underestimate a patient's need to know. This resource is a valuable new tool in the patients’ battle against brain tumors—helpful, supportive, and honest.

 

It is a must-have reference for those living in the brain tumor community.

 

Naomi Berkowitz

Executive Director

American Brain Tumor Association

March 2003


 

The authors, editors, and publisher have made every effort to provide accurate information. However, they are not responsible for errors, omissions, or for any outcomes related to the use of the contents of this book and take no responsibility for the use of any products described herein. Treatments and side effects described in this book may not be applicable to all patients; likewise, some patients may require a dose or experience a side effect that is not described herein. The reader should confer with his or her own physician regarding specific treatments and side effects. Drugs and medical devices are discussed that may have limited availability or be controlled by the Food and Drug Administration (FDA) for use only in a research study or clinical trial. The drug information presented has been derived from reference sources, recently published data, and pharmaceutical research data. Research, clinical practice, and government regulations often change the accepted standard in this field. When consideration is being given to use of any drug in the clinical setting, the health care provider or reader is responsible for determining FDA status of the drug, reading the package insert, reviewing prescribing information for the most up-to-date recommendations on dose, precautions, and contraindications, and determining the appropriate usage for the product. This is especially important in the case of drugs that are new or seldom used. Comments from a patient or patients other than the authors that may be used in this text are the opinions of the commenter and should not be construed as representative of the authors’ or publisher’s viewpoint. 

Acquisitions Editor: Christopher Davis

Production Editor: Elizabeth Platt

Cover Design: Philip Regan

Manufacturing Buyer: Therese Bräuer

Composition: Northeast Compositors

Printing and Binding: Malloy Lithographing

Cover Printer: Malloy Lithographing

Printed in the United States of America

07 06 05 04 03 10 9 8 7 6 5 4 3 2 1

 

Home ] Q&A 100 Introduction ] Part 1 ] Part 2 ] Part 3 ] Part 4 ] Part 5 ] Part 6 ] Part 7 ] Part 8 ] Part 9 ] Part 10 ] Part 11 ] Appendix ]

 

Send mail to webmaster@dfw-neuronetwork.com with questions or comments about this web site.
Copyright © 2004 dfw-neuronetwork
Last modified: Saturday June 18, 2005